The following data is part of a De Novo classification by Allergan with the FDA for Truetear Intranasal Tear Neurostimulator.
DeNovo ID | DEN170086 |
Device Name: | TrueTear Intranasal Tear Neurostimulator |
Classification | Intranasal Electrostimulation Device For Dry Eye Symptoms |
Applicant | Allergan 2525 Dupont Drive Irvine, CA 92612 |
Contact | Nooshin Azizi |
Product Code | QBR |
CFR Regulation Number | 886.5310 [🔎] |
Decision | Granted (DENG) |
510(k) Premarket Notification | Device Classification Under Section 513(f)(2)(de Novo) // Quick Links: Skip To Main Page Content Skip To Search Skip To Topics Menu Skip To Common Lin |
Review Advisory Board | Ophthalmic |
Classification Advisory | Ophthalmic |
Type | Direct |
Date Received | 2017-10-23 |
Decision Date | 2018-05-17 |
FDA Review | Decision Summary |
Reclassification Order: | Reclassification Order |